Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...

Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Idexx Labs' fourth-quarter results easily surpassed analysts' expectations. However, its even stronger guidance for 2025 may have stolen the show. Set to launch its newest diagnostic instrument in ...

Treasury yields and bond yields dropped as investors moved to safer assets. Several large companies, including Tyson Foods and IDEXX Laboratories, reported strong quarterly earnings. AP Stock indexes ...

Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are ...

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 ...

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...

Idexx Laboratories posted higher-than-expected fourth-quarter revenue and provided its outlook for 2025. The veterinary technology-and-testing firm logged net income of $216.1 million, or $2.62 a ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments. Idexx Laboratories offers a variety of products and diagnostic services ...